가상현실기법을 활용한 정신건강교육 및 기술훈련 프로그램의 우울증상 회복 및 자살위험성 감소 효과
Treatment Effect of Psychoeducation and Training Program Using Virtual Reality Technique in the Patients with Depressive Symptoms
0
조회
0
다운로드
25
인용
0
참고문헌
초록
Objectives To compare the clinical effectiveness of the virtual reality (VR) programs in assessing psychosocial problems, improving symptoms, and reducing suicide risk in depressive patients with those of pharmacotherapy. Methods Thirty-six patients were recruited with depression in the treatment group and 22 participants in the healthy control group through internet advertisements between November 2018 and March 2019. Participants in the treatment group were allocated randomly at a 1:1 ratio to either the VR group or pharmacotherapy group. At the baseline, all participants were assessed with a comprehensive battery for their psychological characteristics by structured scales using VR technologies. Assessments of patients in the treatment group were repeated four weeks after therapeutic intervention. The primary outcome measures were the Korean Version of Quick Inventory of Depressive Symptomatology-Self-Report and suicidality scales of the Korean Mini International Neuropsychiatric interview. The borderline personality (Personality Assessment Inventory–Borderline Features Scale) and resilience (Korean Resilience Questionnaire) were also evaluated. Results Twenty-four depressive patients completed the treatment, and the final assessment was conducted after four weeks of treatment. In the initial assessment, the patient group showed significantly higher depressive symptoms, suicidality, borderline personality trait, and lower resilience than healthy control group. After the four-week therapeutic interventions, the VR group showed significant improvement in depression, suicidality, borderline personality trait, and resilience. In addition, there was no significant difference in the treatment efficacy between the VR group and the pharmacotherapy group. Conclusion In this study, the VR treatment program has clear benefits for emotional distress and reducing suicidality in depressive patients. Evidence-based VR treatments may show new clinical potential for depressive disorder.
Abstract
Objectives To compare the clinical effectiveness of the virtual reality (VR) programs in assessing psychosocial problems, improving symptoms, and reducing suicide risk in depressive patients with those of pharmacotherapy. Methods Thirty-six patients were recruited with depression in the treatment group and 22 participants in the healthy control group through internet advertisements between November 2018 and March 2019. Participants in the treatment group were allocated randomly at a 1:1 ratio to either the VR group or pharmacotherapy group. At the baseline, all participants were assessed with a comprehensive battery for their psychological characteristics by structured scales using VR technologies. Assessments of patients in the treatment group were repeated four weeks after therapeutic intervention. The primary outcome measures were the Korean Version of Quick Inventory of Depressive Symptomatology-Self-Report and suicidality scales of the Korean Mini International Neuropsychiatric interview. The borderline personality (Personality Assessment Inventory–Borderline Features Scale) and resilience (Korean Resilience Questionnaire) were also evaluated. Results Twenty-four depressive patients completed the treatment, and the final assessment was conducted after four weeks of treatment. In the initial assessment, the patient group showed significantly higher depressive symptoms, suicidality, borderline personality trait, and lower resilience than healthy control group. After the four-week therapeutic interventions, the VR group showed significant improvement in depression, suicidality, borderline personality trait, and resilience. In addition, there was no significant difference in the treatment efficacy between the VR group and the pharmacotherapy group. Conclusion In this study, the VR treatment program has clear benefits for emotional distress and reducing suicidality in depressive patients. Evidence-based VR treatments may show new clinical potential for depressive disorder.
참고문헌 (25)
- World Health Organization, "Preventing suicide: a global imperative" (2014), World Health Organization
- Holma KM, "Incidence and predictors of suicide attempts in DSM-IV major depressive disorder: a five-year prospective study", Am J Psychiatry, 167, pp.801~808 (2010)
- OECD, "Health at a glance 2015: OECD Indicators" (2015), OECD Publishing
- OECD, "Health at a glance 2019: OECD Indicators" (2019), OECD Publishing
- "Statics of causes of death in Korea, 2017" (2018)[URL]
- Cuijpers P, "Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies", J Clin Psychiatry, 69, pp.1675~1685 (2008)
- McHugh RK, "Patient preference for psychological vs pharmacologic treatment of psychiatric disorders : a meta-analytic review", J Clin Psychiatry, 74, pp.595~602 (2013)
- Freeman D, "Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial", Lancet Psychiatry, 5, pp.625~632 (2018)
- Freeman D, "Virtual reality in the assessment, understanding, and treatment of mental health disorders", Psychol Med, 47, pp.2393~2400 (2017)
- Shah LB, "Efficacy of the virtual reality-based stress management program on stress-related variables in people with mood disorders : the feasibility study", Arch Psychiatr Nurs, 29, pp.6~13 (2015)
- Falconer CJ, "Embodying self-compassion within virtual reality and its effects on patients with depression", BJPsych Open, 2, pp.74~80 (2016)
- Bateman A, "Borderline personality disorder and mood disorders : mentalizing as a framework for integrated treatment", J Clin Psychol, 71, pp.792~804 (2015)
- Linehan MM, "The course and evolution of dialectical behavior therapy", Am J Psychother, 69, pp.97~110 (2015)
- Yoo SW, "Validity of Korean Version of the Mini-International Neuropsychiatric Interview", Anxiety Mood, 2, pp.50~55 (2006)
- 윤지호, "한국어판 우울증상평가척도의 신뢰도 및 타당도 연구", Mood and Emotion, 10(3), pp.131~151 (2012), 대한우울조울병학회
- Rush AJ, "The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression", Biol Psychiatry, 54, pp.573~583 (2003)
- Morey LC, "Personality assessment inventory professional manual" (1991), Psychological Assessment Resources
- Hong SH, "A validation study of the Borderline Personality Disorder Scale in Korean university students", Kor J Clin Psychol, 17, pp.259~271 (1998)
- 신우열, "회복탄력성 검사 지수의 개발 및 타당도 검증", 한국청소년연구, 20(4), pp.105~131 (2009), 한국청소년정책연구원
- Kennedy RS, "Simulator ickness questionnaire: An enhanced method for quantifying simulator sickness", Int J Aviat Psychol, 3, pp.203~220 (1993)
- Bouchard S, "Virtual reality compared with in vivo exposure in the treatment of social anxiety disorder : a three-arm randomised controlled trial", Br J Psychiatry, 210, pp.276~283 (2017)
- Bouchard S, "Side effects of immersions in virtual reality for people suffering from anxiety disorders", J Cyber Ther Rehabil, 2, pp.127~137 (2009)
- Linehan MM, "Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder : a randomized clinical trial and component analysis", JAMA Psychiatry, 72, pp.475~482 (2015)
- Calati R, "Is psychotherapy effective for reducing suicide attempt and non-suicidal self-injury rates? Meta-analysis and meta-regression of literature data", J Psychiatr Res, 79, pp.8~20 (2016)
- Cristea IA, "Efficacy of psychotherapies for borderline personality disorder : a systematic review and meta-analysis", JAMA Psychiatry, 74, pp.319~328 (2017)